LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the journal Neuromodulation: Technology at the Neural Interface has published the full 36-month results ...

U.S. Senator Shelley Moore Capito announced an $11.934 million federal grant has been awarded to the WVU Rockefeller ...

A conceptual paper proposes that distinct neuromodulation pathways may affect overlapping functions through a testable ...

Rechargeable implants lower revision rates and long-term costs, while device miniaturization, high-frequency and burst stimulation expand adoption and differentiate portfolios.Dublin, Oct. (GLOBE ...

A live webcast of the investor conference call will be available online at the investor relations page of the Company’s website at ir.cvrx.com. To listen to the conference call on your telephone, ...

Parasym, the London-based developer of the Nurosym wearable neuromodulation device, published an educational article on ...

Bioness Medical's oral neuromodulation system for rehabilitating stroke patients with gait deficits has secured clearance from the US Food and Drug Administration (FDA). The California-based company's ...

In this 5 Minutes With interview, Kathryn Nichol of LivaNova shares her insights into neuromodulation and her passion for the ...

Spurred by the opioid crisis, a once marginalized therapy that relies on electrical stimulation to treat chronic pain is undergoing a renaissance as device makers race to upgrade their products for a ...

Patients who say their eyes feel dry, gritty, or burning are among the most common in ophthalmology, and treating them well ...

Technology at the Neural Interface has published the full 36-month results from the CORE-VNS study, the first long-term effectiveness evaluation of contemporary VNS Therapy? devices in people with ...